Literature DB >> 27669369

Evaluation of insulin sensitivity and secretion in primary aldosteronism.

Daisuke Watanabe1, Midori Yatabe1, Atsuhiro Ichihara1.   

Abstract

In primary aldosteronism (PA), insulin response to glucose is not fully understood. Insulin action was elucidated using indices in 32 PA and 21 essential hypertension (EH) patients. These patients were evaluated using homeostasis model assessment (HOMA) indices, quantitative insulin sensitivity check index (QUICKI), and insulinogenic index (IGI), which were expressed for insulin sensitivity/secretion and the early phase of insulin secretion. Insulin sensitivity and early phase of insulin secretion were decreased in PA, and there was a negative correlation between serum potassium concentration and insulin sensitivity indices. These findings suggest that glucose intolerance in PA may be caused by hypokalemia-induced insulin resistance and hypokalemia-independent impairment of early-phase insulin secretion.

Entities:  

Keywords:  Insulin action; primary aldosteronism; serum potassium

Mesh:

Substances:

Year:  2016        PMID: 27669369     DOI: 10.1080/10641963.2016.1182176

Source DB:  PubMed          Journal:  Clin Exp Hypertens        ISSN: 1064-1963            Impact factor:   1.749


  6 in total

Review 1.  Secondary diabetes mellitus due to primary aldosteronism.

Authors:  Melpomeni Moustaki; Stavroula A Paschou; Eleni C Vakali; Andromachi Vryonidou
Journal:  Endocrine       Date:  2022-08-24       Impact factor: 3.925

2.  Heterozygosity for a Pathogenic Variant in SLC12A3 That Causes Autosomal Recessive Gitelman Syndrome Is Associated with Lower Serum Potassium.

Authors:  Xuesi Wan; James Perry; Haichen Zhang; Feng Jin; Kathleen A Ryan; Cristopher Van Hout; Jeffrey Reid; John Overton; Aris Baras; Zhe Han; Elizabeth Streeten; Yanbing Li; Braxton D Mitchell; Alan R Shuldiner; Mao Fu
Journal:  J Am Soc Nephrol       Date:  2021-02-04       Impact factor: 10.121

3.  Insulin sensitivity and pancreatic β-cell function in patients with primary aldosteronism.

Authors:  Shivraj Grewal; Andin Fosam; Liam Chalk; Arjun Deven; Mari Suzuki; Ricardo Rafael Correa; Jenny E Blau; Andrew Paul Demidowich; Constantine A Stratakis; Ranganath Muniyappa
Journal:  Endocrine       Date:  2021-01-18       Impact factor: 3.633

4.  Differences in Glycemic Abnormalities Between Primary Aldosteronism and Essential Hypertension: A Systematic Review and Meta-Analysis.

Authors:  Worapaka Manosroi; Pichitchai Atthakomol; Pittaporn Wattanawitawas; Supawan Buranapin
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-31       Impact factor: 6.055

5.  The differences of serum lipid profiles between primary aldosteronism and essential hypertension: a meta-analysis and systematic review.

Authors:  Worapaka Manosroi; Pitchaporn Phudphong; Pichitchai Atthakomol; Mattabhorn Phimphilai
Journal:  BMC Endocr Disord       Date:  2022-08-31       Impact factor: 3.263

6.  Higher Blood Urea Nitrogen and Urinary Calcium: New Risk Factors for Diabetes Mellitus in Primary Aldosteronism Patients.

Authors:  Yu Liu; Liang Zhou; Zhenghuan Liu; Yucheng Ma; Lede Lin; Yuchun Zhu; Kunjie Wang; Hong Li
Journal:  Front Endocrinol (Lausanne)       Date:  2020-02-04       Impact factor: 5.555

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.